Pfizer wins patent dispute over Abboject epinephrine shot

02-09-2021

Muireann Bolger

Pfizer wins patent dispute over Abboject epinephrine shot

Molly Woodward / Shutterstock.com

Belcher’s chief science officer deceived the US Patent and Trademark Office (USPTO) in order to obtain a patent, the US Court of Appeals for the Federal Circuit has ruled in a win for Pfizer’s subsidiary, Hospira.


Pfizer, Abboject, Federal Circuit, patent

LSIPR